Simulations based on disease-progression models and phase II trial results can predict phase III results and have the potential to improve oncology drug development by informing end-of-phase II decisions (EOP2Ds). Many barriers impede effective use of modeling and simulation (M&S) for EOP2Ds in oncology: concerns about model validity, lack of access to M&S results and patient-level data, limite...

The Ministry of Health and Medical Education in Iran designed a comprehensive system as health care excellence model with participation of National Institute of Productivity & Organizational Excellence since January 2011 and introduced it in June 2012. The purpose of this paper is adapting of Joint Commission International Accreditation System in hospital by organizational excellence model in h...

background: nowadays hospitals have to cope with global changes. they are thus forced to be equipped with learning and learning hospitals. this research was performed to design a model for establishing learning organization in iranian public hospitals. methods: this qualitative, comparative, cross-sectional study was conducted in 2009-2010. first, available models of learning organization in ge...